术前18F-FDG PET-CT诊断四肢躯干皮肤黑色素瘤淋巴结转移的价值
该回顾性研究纳入112例四肢及躯干皮肤黑色素瘤患者,评估术前18F-FDG PET-CT诊断淋巴结转移的价值。PET-CT诊断意见对淋巴结状态有独立诊断意义(OR=11.296,95%CI:2.550~50.033),淋巴结最大径、SUV最大值及诊断意见的曲线下面积分别为0.789、0.786和0.816。Breslow厚度≥4.25 mm者生存率较低(P=0.006)。
要点
- PET-CT诊断意见是淋巴结状态的独立诊断指标(OR=11.296)。
- 淋巴结最大径≥0.85 cm或SUV最大值≥1.45时应考虑淋巴结转移可能。
- 原发灶Breslow厚度≥4.25 mm的患者推荐行术前18F-FDG PET-CT检查。
核心结论
- 术前18F-FDG PET-CT有助于四肢及躯干皮肤黑色素瘤的病情评估与治疗决策,尤其适用于原发灶Breslow厚度≥4.25 mm的患者。
研究设计与样本
- 回顾性纳入2006年1月至2016年12月112例四肢及躯干皮肤黑色素瘤患者,术前均行18F-FDG PET-CT检查。
- 以淋巴结最终病理诊断为金标准,采用ROC曲线、二分类逐步Logistic回归及Log rank检验进行分析。
主要发现
- 淋巴结最大径、SUV最大值和PET-CT诊断意见判断淋巴结状态的曲线下面积分别为0.789、0.786和0.816(均P<0.05)。
- 三者的最佳界值分别为0.85 cm、1.45和2.5,敏感度分别为71.4%、64.9%和72.1%,特异度分别为85.2%、88.7%和87.0%。
- 多因素Logistic回归显示PET-CT诊断意见对淋巴结状态有独立诊断意义(OR=11.296,95%CI:2.550~50.033)。
- Breslow厚度判断PET-CT诊断意见的曲线下面积为0.664(P=0.042),最佳界值为4.25 mm。
- Breslow厚度≥4.25 mm组患者生存率低于<4.25 mm组(P=0.006)。
关键数值与推荐
- 淋巴结最大径最佳界值0.85 cm,敏感度71.4%,特异度85.2%。
- 淋巴结SUV最大值最佳界值1.45,敏感度64.9%,特异度88.7%。
- PET-CT诊断意见最佳界值2.5,敏感度72.1%,特异度87.0%。
- Breslow厚度判断PET-CT诊断意见的最佳界值为4.25 mm(曲线下面积0.664,P=0.042)。
临床怎么用
- 对四肢及躯干皮肤黑色素瘤患者,尤其原发灶Breslow厚度≥4.25 mm者,术前可行18F-FDG PET-CT评估淋巴结转移。
- 当最大淋巴结短径≥0.85 cm或区域淋巴结SUV最大值≥1.45时,应考虑淋巴结转移可能并据此制定治疗方案。
局限性
- 本研究为单中心回顾性研究,样本量112例,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the clinical value of preoperative (18)F-Fludeoxyglucose ((18)F-FDG PET-CT) in lymphatic metastasis diagnosis of cutaneous melanoma on extremities and trunk. Methods: 112 patients with cutaneous melanoma pathologically of extremities and trunk from January 2006 to December 2016, who received (18)F-FDG PET-CT examination preoperatively, were retrospectively reviewed. The correlations between the maximal diameters of lymph nodes, the maximal standard uptake value (SUV) and the diagnostic impression grades of PET-CT examination, and the final pathological diagnosis were analyzed. The correlations between Breslow thickness of primary lesions and the diagnostic impression of PET-CT examination were also analyzed. All the above were analyzed with Receiver Operating Characteristic (ROC) curve to get the cut-off value. Based on the final results of pathological diagnosis of lymph nodes as the golden standard, the statistically significant indicators of ROC curve analysis were used to evaluate the diagnostic effect, as well as to calculate the sensitivity, specificity and accuracy. With gender, age, maximal diameter of lymph nodes, maximal SUV, diagnosis impressions, and Breslow thickness as the independent variables and pathological diagnosis results of lymph nodes as the dependent variable, two-class stepwise Logistic regression analysis was used to determine the independence of diagnostic indicators. ROC curve analysis and log rank test were used to analyze the relationship between Breslow thickness and patient survival. Results: To evaluate melanoma patients' lymph node status, the results of ROC curve analysis showed that the area under the curve of lymph node maximal diameter, maximal SUV, diagnosis impression of PET-CT examinations were 0.789, 0.786 and 0.816, respectively (all P<0.05). The cut-off values were 0.85 cm, 1.45 and 2.5, respectively. The sensitivity of the cut-off values to determine the status of lymph nodes in melanoma patients were 71.4%, 64.9% and 72.1% respectively, and the specificities were 85.2%, 88.7% and 87.0% respectively. Multivariate Logistic regression analysis showed that PET-CT diagnosis impressions had independent diagnostic significance for the lymph node status of melanoma patients (OR=11.296, 95%CI: 2.550~50.033). The area under the curve of Breslow thickness evaluating PET-CT diagnostic impression is 0.664 (P=0.042) and the cut-off value was 4.25 mm. The survival rate of the patients with Breslow thickness ≥ 4.25 mm was lower than that in the group <4.25 mm (P=0.006). Conclusions: (18)F-FDG PET-CT can help to evaluate metastases and make treatment decisions for cutaneous melanoma of extremities and trunk, especially for patients whose primary lesion's Breslow thickness has reached more than 4.25 mm. For the patients whose maximal SUV of regional lymph node is higher than 1.45 and short diameter of the largest lymph node is larger than 0.85cm, the possibility of metastases should be considered. 目的:评价术前(18)F-氟代脱氧葡萄糖((18)F-FDG) PET-CT在诊断四肢及躯干皮肤黑色素瘤淋巴结转移中的临床应用价值。 方法:收集112例术前已行(18)F-FDG PET-CT检查的皮肤黑色素瘤患者的临床病理资料。采用受试者工作特征(ROC)曲线分析方法,对PET-CT检查的淋巴结最大径、标准摄取值(SUV)最大值、PET-CT诊断意见分级与最终病理诊断结果进行关联分析,对原发灶Breslow厚度与PET-CT诊断意见进行关联分析,得出最佳界值。以最终的淋巴结病理诊断结果为金标准,对ROC曲线分析有统计学意义的指标进行诊断效果评估,计算敏感度、特异度和准确性。以性别、年龄、淋巴结最大径、SUV最大值、诊断意见、Breslow厚度作为自变量,以淋巴结病理诊断结果为因变量,行二分类逐步Logistic回归分析,明确诊断指标的独立性。采用ROC曲线分析和Log rank检验,分析Breslow厚度与患者生存的关系。 结果: ROC曲线分析结果显示,淋巴结最大径、SUV最大值和PET-CT诊断意见判断黑色素瘤患者淋巴结状态的曲线下面积分别为0.789、0.786和0.816(均P<0.05),最佳界值分别为0.85 cm、1.45和2.5,以此界值判断黑色素瘤患者淋巴结状态的敏感度分别为71.4%、64.9%和72.1%,特异度分别为85.2%、88.7%和87.0%。多因素Logistic回归分析显示,PET-CT诊断意见对于黑色素瘤患者的淋巴结状态具有独立的诊断意义(OR=11.296,95%CI:2.550~50.033)。Breslow厚度判断PET-CT诊断意见的ROC曲线下面积为0.664(P=0.042),最佳界值为4.25 mm。以此界值分组,Breslow厚度≥4.25 mm组患者的生存率低于<4.25 mm组(P=0.006)。 结论:对于发生于四肢及躯干的皮肤黑色素瘤,(18)F-FDG PET-CT有助于评估病情及制订治疗方案,尤其对于原发病灶Breslow厚度≥4.25 mm的患者,推荐行(18)F-FDG PET-CT检查。对于最大淋巴结短径≥0.85 cm、区域淋巴结SUV最大值≥1.45的患者,应考虑淋巴结转移的可能性。.
引用
- Zhang XX, Fang Y, Xu LB, et al. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29860765. doi:10.3760/cma.j.issn.0253-3766.2018.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。